Skip to main content

Table 1 Clinical and laboratory characteristics of patients with gouty arthritis and healthy controls

From: MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis

 

Healthy controls

Patient

Total number

10

14

Age, mean (range) years*

51 (25 to 65)

55 (31 to 68)

Male, number (%)*

10 (100)

14 (100)

Duration of acute gout, mean (range) days

NA

2 (1 to 4)

Co-morbidity

NA

 

  Diabetes, number (%)

 

3 (21.4)

  Hypertension, number (%)

 

4 (28.5)

  Hypercholesterolemia, number (%)

 

1 (7.1)

  Cardiovascular disease, number (%)

 

2 (14.3)

Current medicines

NA

 

  Naive, number (%)

 

14 (100)

Location of arthritis

NA

 

  First MTP joint, number (%)

 

10 (71.4)

  Knee joint, number (%)

 

12 (72.3)

  Ankle joint, number (%)

 

2 (14.3)

Serum urate level, mean (range) mg/dl

NA

7 (5 to 12)

ESR, mean (range, mm/h)

NA

55 (45 to 61)

CRP, mean (range, mg/dL)

NA

12.5 (5.8 to 18.3)

  1. CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; MTP, metatarsophalangeal; NA, not applicable. *Not significant.